|
Friday, November 19, 2021
Print Current Session:
 |
|
|
Friday
SESSION 80:
NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS WITH MESH COVERED STENTS AND TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION (TCAR)
|
|
| SESSION 80 SCHEDULE | |
| MESH COVERED STENTS | |
| 7:53 AM - 7:58 AM | Long-Term Results Of Micromesh Stents Show Their Value In Carotid Artery Stenting (CAS): Are There Limitations: Do The Differences In The 3 Micromesh Stents Matter |
|
Presenter(s):Max Amor, MD Location: Grand Ballroom East, 3rd Floor |
|
| 7:59 AM - 8:04 AM | Advantages And Limitations Of Mesh Covered Stents In CAS: Are They Really Better |
|
Presenter(s):Laura Capoccia, MD Location: Grand Ballroom East, 3rd Floor |
|
| 8:05 AM - 8:10 AM | 7-Year Experience With Micromesh Stents For CAS: Are There Downsides (Thrombosis Or ISR): Technical Tips To Optimize Their Results |
|
Presenter(s):Stefan Müller-Hülsbeck, MD Location: Grand Ballroom East, 3rd Floor |
|
| 8:11 AM - 8:16 AM | Results From A Multicenter Italian Study Of The C-Guard Micromesh Stent For CAS: Advantages And Complications |
|
Presenter(s):Francesco Speziale, MD / Wassim Mansour, MD / Pasqualino Singnano, MD / Carlo Setacci, MD Location: Grand Ballroom East, 3rd Floor |
|
| TCAR RELATED TOPICS | |
| 8:17 AM - 8:22 AM | TCAR Versus CEA (Carotid Endarterectomy): A Propensity Matched SVS VQI Study: 1-Year Results Show Equal Stroke/Death Rates And Decreased Cranial Nerve Injuries With TCAR: Findings Also Confirmed By A Meta-Analysis |
|
Presenter(s):Mahmoud B. Malas, MD, MHS / Marc L. Schermerhorn, MD Location: Grand Ballroom East, 3rd Floor |
|
| 8:23 AM - 8:28 AM | TCAR Versus Transfemoral CAS (TFCAS): A Propensity Matched SVS VQI Study Shows That TCAR Has Lower Stroke And Death Rates Than TFCAS |
|
Presenter(s):Marc L. Schermerhorn, MD / Mahmoud B. Malas, MD, MHS / Vikram S. Kashyap, MD Location: Grand Ballroom East, 3rd Floor |
|
| 8:29 AM - 8:34 AM | Why I Am Uncertain That TCAR Will Have Better Outcomes Than TFCAS: What Does The CREST 2 Registry Show |
|
Presenter(s):Thomas G. Brott, MD / William A. Gray, MD / Giancarlo Biamino, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| 8:35 AM - 8:40 AM | DEBATE: For TFCAS Reversal/ Of Flow With Gore/MoMA Device Cerebral Embolic Protection Is No Better Than Filter Protection: Why Is This So |
|
Presenter(s):Marc L. Schermerhorn, MD Location: Grand Ballroom East, 3rd Floor |
|
| 8:41 AM - 8:46 AM | DEBATE: Not So: In Some Specific Circumstances Reversal/Cessation Of Flow Protection During TFCAS Is Better And Safer Than Filter Protection |
|
Presenter(s):Giancarlo Biamino, MD, PhD / William A. Gray, MD Location: Grand Ballroom East, 3rd Floor |
|
| 8:47 AM - 8:52 AM | Based On Data To Date When Should TCAR Replace CEA And When Should It Not: A Balanced View |
|
Presenter(s):Vikram S. Kashyap, MD Location: Grand Ballroom East, 3rd Floor |
|
| 8:53 AM - 8:58 AM | TCAR Seems Better Than TFCAS And Equal To CEA: It Has A Bright Future: What Are Its Drawbacks |
|
Presenter(s):Wesley S. Moore, MD Location: Grand Ballroom East, 3rd Floor |
|
| 8:59 AM - 9:07 AM | Panel |
| 9:07 AM - 9:17 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 80 | |
| previous | next |